Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » Peter MacCallum 25th Anniversary of PRRT with Professor Rod Hicks

Peter MacCallum 25th Anniversary of PRRT with Professor Rod Hicks

  • September 12, 2021

On Sunday September 12, NeuroEndocrine Cancer Australia and Peter MacCallum Cancer Centre celebrated 25 years of Peptide Receptor Radionuclide Therapy (PRRT).

We were so pleased to see such a large turn out from our neuroendocrine cancer community, all keen to support each other and pay tribute to what has been an incredible 25 years of PRRT, lead by Professor Rod Hicks.

Throughout the afternoon we heard from:

Professor Rod Hicks, the Honorary Victorian Governor Linda Dessau AC, Peter MacCallum Cancer Centre CEO Prof Shelley Dolan, A/Prof Kong and Simone Leyden representing NECA. 

A/Prof Grace Kong guided us through the latest in clinical research before we were privy to a mock NET MDT meeting with leading specialists from Peter MacCallum including; Prof Michael, A/Prof Kong, A/Prof Cherie Chiang, Dr Bill Murray, Dr Benjamin Loveday, Dr Phil Chan, Meg Rogers & Leah Neeson. This was an informative insight into what is taken in to consideration, when decisions are made for optimal patient care and treatment.

We thank everyone involved who took the time to record a very moving tribute video to Professor Rod Hicks who is stepping down from his role as Director of molecular imaging and therapeutic nuclear medicine. This video was a fitting end to what was an incredibly insightful, informative and warm afternoon. 

We were delighted that well over 100 friends of Peter MacCallum Cancer Centre and NeuroEndocrine Cancer Australia took time out of their Sunday join us for the afternoon and enjoy a rare glimpse into treatment and care from a healthcare specialist perspective.

If you have not yet had a chance to watch, or wish to share this event with your friends, please click the link below.

Watch recording here

Share this post

Recent posts

Be the Voice for NET Patients in WA – Join Our CAG Team

June 10, 2025

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousIntroducing Australian Rare Cancer Portal
NextAction plan support – short videos wanted!Next

Related Posts

Be the Voice for NET Patients in WA – Join Our CAG Team

Call out for a consumer advisory representative from Western Australia (voluntary position) Are you from Western Australia? Have you experienced a diagnosis of a Neuroendocrine

BioPharmaDispatch 2025: Putting NETs on the National Agenda

BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin